Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-046148

Director bought 111,111 shares at $0.90 ($100,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Donenberg Phillip B. Director 2023-08-16 Purchase +111,111 $0.90 $100,000 114,111 D
Open-market purchases · 111,111 sh · avg $0.90 · $100,000
Loading xslF345X05/doc4.xml…